News Archive

EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)

1st March 2023

20 - 23 February 2023

Read More+

EMA - CTIS newsflash – 24 February 2023

1st March 2023

With the aim to enhance communication with the CTIS user community, this regular CTIS newsflash provides key updates on CTIS and links to useful reference materials.

Read More+

EMA - Clinical Trials Highlights

1st March 2023

February 2023

Read More+

EMA - Veterinary medicines: highlights of 2022

1st March 2023

EMA has published an PDF icon overview of its key recommendations of 2022 regarding the authorisation and safety monitoring of veterinary medicines.

Read More+

MHRA - Drug Safety Update: monthly PDF newsletter

1st March 2023

Monthly PDF editions of the Drug Safety Update newsletter from MHRA and its independent advisor, the Commission on Human Medicines

Read More+

MHRA - Impact of extension of Medical Device Regulations transitional period and the validity of certificates in the EU

1st March 2023

The European Parliament has voted to adopt an extension of the transition period for the EU Medical Device Regulations and to extend the validity of certain device certificates

Read More+

MHRA - MHRA Board Meeting held in public

1st March 2023

Date: Tuesday 21 March 2023/Location: Webinar

Read More+

Meeting highlights from the CVMP 14-16 February 2023

1st March 2023

14-16 February 2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 2023

Read More+

HRA - #makeitpublic Week

27th February 2023

HRA's Make it Public strategy signals an ambition to transform research transparency in the UK.

Read More+

HRA Blog - Patients need access to industry clinical trials

27th February 2023

In October 2022, the Association for the British Pharmaceutical Industry reported that the number of clinical trials run by pharmaceutical companies in the UK had declined over recent years. In October 2022, the Association for the British Pharmaceutical Industry reported that the number of clinical trials run by pharmaceutical companies in the UK had declined over recent years. This wasn’t a case of industry just complaining about how hard it is to run their business. More importantly, they explained the impact this is having on the NHS and all of us as patients. And it’s not good news.

Read More+